Physician profile
Ashley B Lee
NPI 1346214350
$1,450.37
in general payments reported to CMS, 2019-2025
15 companies · $703 in 2025
The $703 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.92 · 2020: $125 · 2021: $36.95 · 2022: $81.23 · 2023: $116 · 2024: $361 · 2025: $703.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,180.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $527.02 | 2021-2025 | Ultreon, Triclip, Coroflow |
| Abiomed | $230.47 | 2019-2025 | Impella |
| Amarin Pharma, INC. | $125.00 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $116.84 | 2023-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $105.05 | 2023-2024 | Jardiance |
| Amgen INC. | $87.75 | 2024-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $79.78 | 2024-2025 | Avvigo Guidance System |
| Livanova USA, INC. | $39.59 | 2025 | Tandemheart |
| Stryker Corporation | $29.63 | 2025 | Flowtriever |
| Cardiovascular Systems INC. | $28.14 | 2022 | |
| Heartflow, INC. | $21.50 | 2025 | |
| W. L. Gore & Associates, INC. | $18.39 | 2025 | Gore Cardioform Septal Occluder |
| Astrazeneca Pharmaceuticals LP | $15.37 | 2022 | |
| Cardiva Medical, INC. | $13.88 | 2022 | |
| Edwards Lifesciences Corporation | $11.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.